Role of PET/CT scanning in initial and post-treatment assessment of Hodgkin disease.
The add-on value of F18-fluorodeoxyglucose PET, particularly when combined with CT, to the conventional workup in managing patients with Hodgkin disease has now been well documented. This article reviews the use of these imaging modalities in the initial staging and post-treatment assessment of Hodgkin disease.